MED15 and breast carcinoma: MED15 modulates transforming growth factor β (TGFβ)/Smad signaling during development24 and breast cancer cell metastasis25; MED15 deficiency attenuates TGFβ-targeted gene expression and relieves TGFβ-mediated growth inhibition and metastasis25.